StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Down down down

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Dec 21, 2021 10:05am

116 Views

Post# 34250120

RE:RE:Down down down

Trade restrictions? Only thing I ever heard of was Scotia and who uses them lol. Bunch of small retail that could easily switch platforms. Not significant

bigstar10 wrote: Yep, sad.......until they clean up the issues with the trading platforms to be able to buy shares (eliminate trade restrictions) this will be a duck with a broken leg

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December